B6.129P2-Plxnb2tm1Matl/Ieg

Status

Available to order

EMMA IDEM:03098
Citation informationRRID:IMSR_EM:03098 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.129P2-Plxnb2tm1Matl/Ieg
Alternative namePlexin-B2 KO
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolPlxnb2tm1Matl
Gene/Transgene symbolPlxnb2

Information from provider

ProviderRoland Friedel
Provider affiliationSoriano Lab, Department of Developomental & Regenerative Biology, Mount Sinai School of Medicine
Genetic informationOfficial allele name: Plxnb2tm1Matl. Knock-out by targeted trapping of the Plexin-B2 (Plxnb2) gene. Targeted mutagenesis using a promoterless gene trap vector ("targeted trapping") was used to insert a 9.4-kb placental alkaline phosphatase (PLAP) secretory cassette into the intron between exons 16 and 17 (counting the exon containing the translational start site as exon 1). This results in transcription of a fusion mRNA joining exons 1-16 of the endogenous gene to the elements of the cassette, comprising a splice acceptor and a transmembrane domain coding sequence followed by the betageo (lacZ/neomycin resistance fusion) cDNA, an internal ribosomal entry site (IRES), and the human PLAP sequence with a polyadenylation signal. Two proteins are translated from this bicistronic transcript: a Plxnb2/Betageo fusion protein that is sequestered in an intracellular compartment of the neuronal cell body; and PLAP, which is expressed on the axonal surface.
Phenotypic informationHomozygous mutation causes exencephaly with high penetrance (surviving mutants can be generated by outcrossing to CD1; these surviving hybrid mutants reveal malformation of cerebellar cortex).
Breeding historyBackcrossed to C57BL/6 for 13 generations.
References
  • Plexin-B2 controls the development of cerebellar granule cells.;Friedel Roland H, Kerjan Géraldine, Rayburn Helen, Schüller Ulrich, Sotelo Constantino, Tessier-Lavigne Marc, Chédotal Alain, ;2007;The Journal of neuroscience : the official journal of the Society for Neuroscience;27;3921-32; 17409257
  • Gene targeting using a promoterless gene trap vector ("targeted trapping") is an efficient method to mutate a large fraction of genes.;Friedel Roland H, Plump Andrew, Lu Xiaowei, Spilker Kerri, Jolicoeur Christine, Wong Karen, Venkatesh Tadmiri R, Yaron Avraham, Hynes Mary, Chen Bin, Okada Ami, McConnell Susan K, Rayburn Helen, Tessier-Lavigne Marc, ;2005;Proceedings of the National Academy of Sciences of the United States of America;102;13188-93; 16129827
Homozygous fertileno
Homozygous viableno
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreHelmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany
Animals used for archivingheterozygous C57BL/6J males, wild-type C57BL/6J females
Stage of embryos2-cell

Disease and phenotype information

IMPC phenotypes (gene matching)
  • increased IgE level / IMPC
  • abnormal urination / IMPC
  • abnormal response to tactile stimuli / IMPC
MGI phenotypes (allele matching)
  • abnormal cerebellar granule cell migration / MGI
  • vision/eye phenotype / MGI
  • exencephaly / MGI
  • incomplete rostral neuropore closure / MGI
  • small kidney / MGI
  • curly tail / MGI
  • spina bifida / MGI
  • renal hypoplasia / MGI
  • duplex kidney / MGI
  • impaired branching involved in ureteric bud morphogenesis / MGI
  • neonatal lethality, incomplete penetrance / MGI
  • double ureter / MGI
  • abnormal ureteric bud tip morphology / MGI
  • double kidney pelvis / MGI
  • incomplete caudal neuropore closure / MGI
  • belly spot / MGI
  • abnormal cerebellum morphology / MGI
  • small cerebellum / MGI
  • abnormal cerebellar foliation / MGI
  • abnormal cerebellum external granule cell layer morphology / MGI
  • abnormal cerebellar Purkinje cell layer / MGI
  • ectopic Purkinje cell / MGI
  • abnormal cerebellar granule layer morphology / MGI
  • ectopic cerebellar granule cells / MGI
  • abnormal radial glial cell morphology / MGI
  • abnormal cerebellar cortex morphology / MGI
  • abnormal rostral migratory stream morphology / MGI
  • behavior/neurological phenotype / MGI
  • reproductive system phenotype / MGI
  • abnormal neuronal migration / MGI
  • abnormal olfactory bulb interneuron morphology / MGI
  • abnormal olfactory bulb granule cell morphology / MGI
  • abnormal olfactory bulb periglomerular cell morphology / MGI
  • abnormal olfactory bulb layer morphology / MGI
  • abnormal olfactory bulb internal plexiform layer morphology / MGI
  • abnormal olfactory bulb mitral cell layer morphology / MGI
  • decreased neuronal precursor proliferation / MGI
MGI phenotypes (gene matching)
  • belly spot / MGI
  • abnormal choroid plexus morphology / MGI
  • abnormal brain ventricle morphology / MGI
  • abnormal diencephalon morphology / MGI
  • abnormal cerebellum morphology / MGI
  • small cerebellum / MGI
  • absent cerebellar foliation / MGI
  • abnormal cerebellar foliation / MGI
  • abnormal cerebellum external granule cell layer morphology / MGI
  • abnormal cerebellar Purkinje cell layer / MGI
  • ectopic Purkinje cell / MGI
  • abnormal cerebellar granule layer morphology / MGI
  • exencephaly / MGI
  • incomplete rostral neuropore closure / MGI
  • open neural tube / MGI
  • abnormal coat/hair pigmentation / MGI
  • abnormal neural tube morphology / MGI
  • abnormal brain morphology / MGI
  • abnormal olfactory bulb development / MGI
  • ectopic cerebellar granule cells / MGI
  • small kidney / MGI
  • curly tail / MGI
  • spina bifida / MGI
  • renal hypoplasia / MGI
  • abnormal radial glial cell morphology / MGI
  • duplex kidney / MGI
  • abnormal striatum morphology / MGI
  • abnormal cerebellar cortex morphology / MGI
  • abnormal cerebellar granule cell morphology / MGI
  • abnormal rostral migratory stream morphology / MGI
  • impaired branching involved in ureteric bud morphogenesis / MGI
  • behavior/neurological phenotype / MGI
  • reproductive system phenotype / MGI
  • vision/eye phenotype / MGI
  • abnormal neuronal migration / MGI
  • abnormal olfactory bulb interneuron morphology / MGI
  • abnormal olfactory bulb granule cell morphology / MGI
  • abnormal olfactory bulb periglomerular cell morphology / MGI
  • abnormal olfactory bulb layer morphology / MGI
  • abnormal olfactory bulb internal plexiform layer morphology / MGI
  • abnormal olfactory bulb mitral cell layer morphology / MGI
  • abnormal cerebellar granule cell migration / MGI
  • neonatal lethality, incomplete penetrance / MGI
  • prenatal lethality, complete penetrance / MGI
  • enlarged brain ventricles / MGI
  • double ureter / MGI
  • abnormal ureteric bud tip morphology / MGI
  • double kidney pelvis / MGI
  • incomplete caudal neuropore closure / MGI
  • decreased neuronal precursor proliferation / MGI

Literature references

  • Plexin-B2 controls the development of cerebellar granule cells.;Friedel Roland H, Kerjan Géraldine, Rayburn Helen, Schüller Ulrich, Sotelo Constantino, Tessier-Lavigne Marc, Chédotal Alain, ;2007;The Journal of neuroscience : the official journal of the Society for Neuroscience;27;3921-32; 17409257
  • Gene targeting using a promoterless gene trap vector ("targeted trapping") is an efficient method to mutate a large fraction of genes.;Friedel Roland H, Plump Andrew, Lu Xiaowei, Spilker Kerri, Jolicoeur Christine, Wong Karen, Venkatesh Tadmiri R, Yaron Avraham, Hynes Mary, Chen Bin, Okada Ami, McConnell Susan K, Rayburn Helen, Tessier-Lavigne Marc, ;2005;Proceedings of the National Academy of Sciences of the United States of America;102;13188-93; 16129827

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).